Department of Medicine, North Shore University Hospital, Northwell Health, Manhasset, NY, USA.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, North Shore University Hospital, 300 Community Drive, Manhasset, NY, 11030, USA.
J Gen Intern Med. 2024 Aug;39(10):1895-1900. doi: 10.1007/s11606-024-08736-4. Epub 2024 Apr 8.
Inpatient use of insulin pump therapy has been increasing due to greater availability of this technology, however there is a paucity of research that investigates glycemic control of inpatient insulin pump users.
To compare the glycemic control of hospitalized patients with type 1 diabetes (T1D) who used insulin pump vs. multiple daily injections (MDI).
Retrospective chart review.
Patients with T1D who were hospitalized between January 1, 2017, and December 31, 2019, in an academic medical center in the New York metropolitan area.
Patients were categorized into three groups based on their method of insulin administration: "pump only" group used insulin pump exclusively, "MDI only" group used MDI only, and "intermittent pump" group used a combination of both methods. The primary endpoints are mean blood glucose, rates of hypoglycemic events (blood glucose < 70 mg/dL), and rates of hyperglycemic events (blood glucose > 250 mg/dL). Separate multivariable Poisson regressions were performed to determine the association between the type of insulin administration and rate outcomes (i.e., rate of hypoglycemic events and rate of hyperglycemic events).
The study included 78 patients with a mean age of 51, who were mostly male (54%), and white (72%). The average proportion of glucose measurements that were hyperglycemic for the "pump only", "MDI only", and "intermittent pump" groups were 0.11 (SD = 0.11), 0.25 (SD = 0.19), and 0.24 (SD = 0.25), respectively. The "pump only" group has a significantly lower proportion of hyperglycemic events as compared to the "MDI only" group (p = 0.0227).
In this sample, patients who exclusively used their insulin pump while inpatient had a lower rate of hyperglycemic events than patients who used MDI only; suggesting that select patients can safely continue their insulin pump therapy in the inpatient setting.
由于胰岛素泵技术的普及,住院患者使用胰岛素泵治疗的情况有所增加,但关于住院胰岛素泵使用者血糖控制的研究却很少。
比较使用胰岛素泵和多次皮下注射(MDI)的住院 1 型糖尿病(T1D)患者的血糖控制情况。
回顾性图表审查。
2017 年 1 月 1 日至 2019 年 12 月 31 日期间在纽约都会区一所学术医疗中心住院的 T1D 患者。
根据胰岛素给药方式将患者分为三组:“仅泵组”仅使用胰岛素泵,“仅 MDI 组”仅使用 MDI,“间歇泵组”使用两种方法的组合。主要终点是平均血糖、低血糖事件发生率(血糖 < 70mg/dL)和高血糖事件发生率(血糖 > 250mg/dL)。分别进行多变量泊松回归以确定胰岛素给药类型与结局(即低血糖事件发生率和高血糖事件发生率)之间的关联。
研究纳入了 78 名平均年龄为 51 岁的患者,其中大多数为男性(54%)和白人(72%)。“仅泵组”、“仅 MDI 组”和“间歇泵组”的血糖测量值中,血糖升高的平均比例分别为 0.11(SD=0.11)、0.25(SD=0.19)和 0.24(SD=0.25)。与“仅 MDI 组”相比,“仅泵组”低血糖事件的比例显著降低(p=0.0227)。
在本样本中,与仅使用 MDI 的患者相比,住院期间仅使用胰岛素泵的患者发生高血糖事件的比例较低;这表明某些患者可以在住院环境中安全地继续使用胰岛素泵治疗。